Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FTH compared with DBVT: revenue, margins and what each company keeps, and the suppliers and customers both name
FTH
Faeth Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
DBVT
DBV Technologies S.A.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FTH
Faeth Therapeutics, Inc.
vs
DBVT
DBV Technologies S.A.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only FTH
2
TAK
Takeda Pharmaceutical
supplier
—
The Regents of the University of California
unlisted
supplier
Shared
0
No shared counterparties.
Only DBVT
1
SNY
Sanofi
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
FTH
Faeth Therapeutics, Inc.
Change
19.46
· pre 19.45
· delayed
Mkt cap
$483.0M
Revenue
—
Revenue
—
DBVT
DBV Technologies S.A.
Change
9.02
· pre 9.02
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$569.0M
Revenue
$2M
Q3 FY26
Revenue
$6M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
FTH
Faeth Therapeutics, Inc.
vs
DBVT
DBV Technologies S.A.
19.46
pre 19.45
delayed
Price
9.02
pre 9.02
delayed
$483.0M
Mkt cap
$569.0M
—
Revenue
$2M
Q3 FY26
—
Revenue
$6M
FY25
Change
Change
FTH
19.46
vs
DBVT
9.02
Pre-market
Nov 2 '26
delayed